{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:32:15Z","timestamp":1777617135714,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bjid.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T05:40:25Z","timestamp":1471153225000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum levels of vancomycin: is there a prediction using doses in mg\/kg\/day or m2\/day for neonates?"],"prefix":"10.1016","volume":"20","author":[{"given":"Roberta Maia de Castro","family":"Romanelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00eani M\u00e1rcia","family":"Anchieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Chaves Abreu","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Antunes Faria","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta\u00eds Marina de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanessa Trindade","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Augusto Moreira","family":"Camargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2016.06.008_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clp.2014.10.013","article-title":"Staphylococcal infections in infants updates and current challenges","volume":"42","author":"Blanchard","year":"2015","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.bjid.2016.06.008_bib0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijmm.2014.04.013","article-title":"The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil?","volume":"304","author":"Dong","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.bjid.2016.06.008_bib0165","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.arcped.2013.06.024","article-title":"Highlights in 2013 around management of late-onset sepsis due to coagulase-negative staphylococci in neonatal intensive care units","volume":"20","author":"Rasigade","year":"2013","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.bjid.2016.06.008_bib0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CP201456","article-title":"Pharmacokinetcs of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital","volume":"49","author":"Badran","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.bjid.2016.06.008_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.spid.2006.06.005","article-title":"Coagulase-negative staphylococcal infections in the neonate and child: an update","volume":"17","author":"Venkatesh","year":"2006","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.bjid.2016.06.008_bib0180","first-page":"1","article-title":"Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive staphylococcal infections","author":"Chhim","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.bjid.2016.06.008_bib0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clinthera.2010.03.005","article-title":"Prediction of vancomycin pharmacodynamics in children with invasive methicilin-resistant Staphylococcus aureus infections: a Monte Carlo simulation","volume":"32","author":"Frymoyer","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.bjid.2016.06.008_bib0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","article-title":"Vancomycin: pharmacokinetics and administration regimens in neonates","volume":"43","author":"De Hoog","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjid.2016.06.008_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2016.06.008_bib0200","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/INF.0000000000000664","article-title":"Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients","volume":"34","author":"Ringenberg","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2016.06.008_bib0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/pch\/19.6.e30","article-title":"Assessment of initial vancomycin dosing in neonates","volume":"19","author":"Dersch-Mills","year":"2014","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.bjid.2016.06.008_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0041-87812001000100004","article-title":"Monitoring the treatment of sepsis with vancomycin in term newborn infants","volume":"56","author":"Machado","year":"2001","journal-title":"Vet Hosp Clin Fac Med"},{"key":"10.1016\/j.bjid.2016.06.008_bib0215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1067\/mcp.2000.105353","article-title":"Vacomycin population pharmacokinetics in neonates","volume":"67","author":"De Hoog","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bjid.2016.06.008_bib0220","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/AAC.01718-13","article-title":"Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations","volume":"58","author":"Kim","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2016.06.008_bib0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/archdischild-2012-302765","article-title":"Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring","volume":"98","author":"Zhao","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bjid.2016.06.008_bib0230","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/j.1875-9114.2012.01029.x","article-title":"Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations","volume":"32","author":"Mehrotra","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bjid.2016.06.008_bib0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/adc.2010.196402","article-title":"Vancomycin prescription in neonates and young infants: toward a simplified dosage","volume":"96","author":"Oudin","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"10.1016\/j.bjid.2016.06.008_bib0240","first-page":"1625","article-title":"Monitoring serum vancomycin concentrations in the treatment of staphylococcus infections in children","volume":"15","author":"Mariani-Kurkdjian","year":"2008","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.bjid.2016.06.008_bib0245","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1093\/jac\/dkr351","article-title":"Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units","volume":"66","author":"Kandabari","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2016.06.008_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.siny.2012.10.003","article-title":"Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration","volume":"18","author":"Jacqz-Aigrain","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.bjid.2016.06.008_bib0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/adc.2007.128280","article-title":"Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule","volume":"93","author":"Plan","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"10.1016\/j.bjid.2016.06.008_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/jcrc.2000.0150001","article-title":"Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function","volume":"15","author":"Glover","year":"2000","journal-title":"J Crit Care"},{"key":"10.1016\/j.bjid.2016.06.008_bib0265","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0169-409X(03)00030-9","article-title":"Pharmacokinetics in the newborn","volume":"55","author":"Alcorn","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bjid.2016.06.008_bib0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2005.12.001","article-title":"Pharmacological research in pediatrics: from neonates to adolescents","volume":"58","author":"Rakhmanina","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bjid.2016.06.008_bib0275","first-page":"450","article-title":"Development and implementation of pediatric formulary & drug therapy guide in a tertiary care hospital in India","volume":"6","author":"Sivadas","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.bjid.2016.06.008_bib0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/S1807-59322007000400006","article-title":"Vancomycin pharmacokinetics in preterm infants","volume":"62","author":"Machado","year":"2007","journal-title":"Clinics"},{"key":"10.1016\/j.bjid.2016.06.008_bib0285","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/INF.0000000000000243","article-title":"Neonatal vancomycin continuous: still a confusion?","volume":"33","author":"Gwee","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2016.06.008_bib0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2165\/00003088-199733010-00004","article-title":"Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children","volume":"33","author":"Rodvold","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjid.2016.06.008_bib0295","doi-asserted-by":"crossref","first-page":"831","DOI":"10.6061\/clinics\/2012(07)21","article-title":"Clinical pharmacokinetics of vancomycin in the neonate: a review","volume":"67","author":"Pacifi","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.bjid.2016.06.008_bib0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40121-015-0067-9","article-title":"Predictive performance of vancomycin population pharmacokinetic model in neonates","volume":"4","author":"Stockmann","year":"2015","journal-title":"Infect Dis Ther"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016301222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016301222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T10:54:51Z","timestamp":1568285691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867016301222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1413867016301222"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2016.06.008","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum levels of vancomycin: is there a prediction using doses in mg\/kg\/day or m2\/day for neonates?","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}